Compass Pathways PLC (CMPS)
8.74
+0.21
(+2.46%)
USD |
NASDAQ |
May 06, 10:16
Compass Pathways Market Cap: 561.35M for May 6, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 547.86M |
| May 02, 2024 | 529.88M |
| May 01, 2024 | 544.65M |
| April 30, 2024 | 550.43M |
| April 29, 2024 | 520.88M |
| April 26, 2024 | 509.97M |
| April 25, 2024 | 504.83M |
| April 24, 2024 | 520.24M |
| April 23, 2024 | 529.88M |
| April 22, 2024 | 536.94M |
| April 19, 2024 | 538.23M |
| April 18, 2024 | 540.79M |
| April 17, 2024 | 547.86M |
| April 16, 2024 | 563.92M |
| April 15, 2024 | 534.37M |
| April 12, 2024 | 556.21M |
| April 11, 2024 | 589.61M |
| April 10, 2024 | 588.97M |
| April 09, 2024 | 614.66M |
| April 08, 2024 | 625.57M |
| April 05, 2024 | 610.16M |
| April 04, 2024 | 629.43M |
| April 03, 2024 | 623.01M |
| April 02, 2024 | 606.95M |
| April 01, 2024 | 621.72M |
| Date | Value |
|---|---|
| March 28, 2024 | 534.37M |
| March 27, 2024 | 610.16M |
| March 26, 2024 | 597.96M |
| March 25, 2024 | 588.97M |
| March 22, 2024 | 576.76M |
| March 21, 2024 | 610.16M |
| March 20, 2024 | 628.14M |
| March 19, 2024 | 612.09M |
| March 18, 2024 | 628.79M |
| March 15, 2024 | 635.85M |
| March 14, 2024 | 629.11M |
| March 13, 2024 | 684.66M |
| March 12, 2024 | 690.77M |
| March 11, 2024 | 685.31M |
| March 08, 2024 | 698.79M |
| March 07, 2024 | 724.49M |
| March 06, 2024 | 700.72M |
| March 05, 2024 | 698.15M |
| March 04, 2024 | 738.62M |
| March 01, 2024 | 737.33M |
| February 29, 2024 | 659.62M |
| February 28, 2024 | 794.49M |
| February 27, 2024 | 752.10M |
| February 26, 2024 | 685.95M |
| February 23, 2024 | 654.48M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
287.38M
Minimum
May 11 2022
2.127B
Maximum
Dec 23 2020
832.48M
Average
592.34M
Median
Sep 13 2022
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 291.25M |
| Biodexa Pharmaceuticals Plc | 4.867M |
| Verona Pharma PLC | 1.260B |
| NuCana PLC | 8.373M |
| Autolus Therapeutics PLC | 1.101B |
Market Cap Related Metrics
| Price to Book Value | 2.487 |
| Price | 8.74 |
| Earnings Yield | -27.06% |